Nilrise Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.40 M
as on 24-10-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.16 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.00 M
as on 24-10-2024
- Revenue -14.60%
(FY 2023)
- Profit -56.36%
(FY 2023)
- Ebitda -31.82%
(FY 2023)
- Net Worth 16.33%
(FY 2023)
- Total Assets 27.88%
(FY 2023)
About Nilrise Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹2.16 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jitendrabhai Lakhani, Hardikkumar Vaghasiya, and Hiral Patel serve as directors at the Company.
- CIN/LLPIN
U51101GJ2014PTC078226
- Company No.
078226
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nilrise Pharmaceuticals Private Limited offer?
Nilrise Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, PCD Pharma Franchise, Pain Relief Drugs & Pharmaceuticals, Pain Reliever Gel, Aceclofenac Tablet, Aceclofenac Paracetamol Serratiopeptidase Tablet, Pharma Franchise, Allopathic PCD Pharma Franchise, Metformin Tablets, Glimepiride Metformin Tablet.
Who are the key members and board of directors at Nilrise Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendrabhai Lakhani  | Managing Director | 09-Jan-2014 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hardikkumar Vaghasiya | Director | 09-Jan-2014 | Current |
| Hiral Patel | Director | 09-Jan-2014 | Current |
Financial Performance of Nilrise Pharmaceuticals.
Nilrise Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.6% decrease. The company also saw a substantial fall in profitability, with a 56.36% decrease in profit. The company's net worth Soared by an impressive increase of 16.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nilrise Pharmaceuticals?
In 2023, Nilrise Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Healthiza Lifescience Private LimitedActive 4 years 10 daysJitendrabhai Lakhani and Hardikkumar Vaghasiya are mutual person
Crinova Healthcare Private LimitedActive 5 years 7 monthsJitendrabhai Lakhani, Hardikkumar Vaghasiya and 1 more are mutual person
Irenic Capitals Private LimitedActive 2 years 10 monthsJitendrabhai Lakhani and Hiral Patel are mutual person
- Opurik Innovation Private LimitedActive 2 years 3 months
Jitendrabhai Lakhani and Hiral Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Jun 2022 | ₹1.61 Cr | Open |
Axis Bank Limited Creation Date: 15 Jul 2021 | ₹0.70 M | Open |
Axis Bank Limited Creation Date: 21 Aug 2019 | ₹4.85 M | Open |
How Many Employees Work at Nilrise Pharmaceuticals?
Nilrise Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nilrise Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nilrise Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
